Activation of latent transforming growth factor  (TGF-) by ␣v6 integrin is critical in the pathogenesis of lung injury and fibrosis. We have previously demonstrated that the stimulation of protease activated receptor 1 promotes ␣v6 integrin-mediated TGF- activation via RhoA, which is known to modulate cell contraction. However, whether other G protein-coupled receptors can also induce ␣v6 integrinmediated TGF- activation is unknown; in addition, the ␣v6 integrin signaling pathway has not yet been fully characterized. In this study, we show that lysophosphatidic acid (LPA) induces ␣v6-mediated TGF- activation in human epithelial cells via both RhoA and Rho kinase. Furthermore, we demonstrate that LPA-induced ␣v6 integrin-mediated TGF- activity is mediated via the LPA2 receptor, which signals via G␣ q . Finally, we show that the expression levels of both the LPA2 receptor and ␣v6 integrin are upregulated and are spatially and temporally associated following bleomycin-induced lung injury. Furthermore, both the LPA2 receptor and ␣v6 integrin are up-regulated in the overlying epithelial areas of fibrosis in patients with usual interstitial pneumonia. These studies demonstrate that LPA induces ␣v6 integrin-mediated TGF- activation in epithelial cells via LPA2 , G␣ q , RhoA , and Rho kinase , and that this pathway might be clinically relevant to the development of lung injury and fibrosis. (Am J Pathol